• A study comparing prasinezumab with placebo for people with early-stage Parkinson’s disease

    Recruiting

    3 1
    Investigated Drugs:
    Austria Denmark France Germany Italy The Netherlands +3
  • Study of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +7
  • A Study of Orforglipron for Knee Pain Relief in Adults with Obesity or Overweight and Knee Osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    Germany Spain
  • Study of STK-012 Alone and Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Ireland Italy Poland Spain
  • Study of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back

    Recruiting

    2 1 1 1
    Belgium France Italy The Netherlands Spain
  • Testing MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment

    Recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Greece +7
  • A study on the long-term effectiveness and safety of nine-valent human papillomavirus vaccine in women aged 16 to 26 years for prevention of cervical cancer

    Recruiting

    3 1 1 1
    Denmark Norway Sweden
  • A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

    Recruiting

    3 1
    Investigated Drugs:
    Bulgaria Finland France Germany Italy Poland +2
  • Study of oral cladribine compared to placebo for patients with generalized myasthenia gravis

    Recruiting

    3 1 1
    Investigated Diseases:
    Belgium Bulgaria Czechia France Germany Greece +6
  • A Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

    Recruiting

    2 1 1 1
    Belgium France Ireland Italy Poland Spain

powered by